Treatment outcomes and cost comparisons for older adults with T4 laryngeal squamous cell cancer.

Jessica D McDermott,Arya Amini,Elizabeth Molina,William A Stokes,Sana D Karam

Head & neck（2023）

引用 1|浏览18

暂无评分

摘要

Older patients with T4 larynx cancer had similar survival rates when treated with CR, SR, and SCR. Average total health care costs were not significantly different between modalities. Patients not eligible for triple-modality could consider these other treatment options.

查看译文

关键词

HNSCC,Medicare,SEER,T4,larynx

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要